Your browser doesn't support javascript.
loading
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Coignard, Juliette; Lush, Michael; Beesley, Jonathan; O'Mara, Tracy A; Dennis, Joe; Tyrer, Jonathan P; Barnes, Daniel R; McGuffog, Lesley; Leslie, Goska; Bolla, Manjeet K; Adank, Muriel A; Agata, Simona; Ahearn, Thomas; Aittomäki, Kristiina; Andrulis, Irene L; Anton-Culver, Hoda; Arndt, Volker; Arnold, Norbert; Aronson, Kristan J; Arun, Banu K; Augustinsson, Annelie; Azzollini, Jacopo; Barrowdale, Daniel; Baynes, Caroline; Becher, Heko; Bermisheva, Marina; Bernstein, Leslie; Bialkowska, Katarzyna; Blomqvist, Carl; Bojesen, Stig E; Bonanni, Bernardo; Borg, Ake; Brauch, Hiltrud; Brenner, Hermann; Burwinkel, Barbara; Buys, Saundra S; Caldés, Trinidad; Caligo, Maria A; Campa, Daniele; Carter, Brian D; Castelao, Jose E; Chang-Claude, Jenny; Chanock, Stephen J; Chung, Wendy K; Claes, Kathleen B M; Clarke, Christine L; Collée, J Margriet; Conroy, Don M; Czene, Kamila; Daly, Mary B.
Afiliação
  • Coignard J; Genetic Epidemiology of Cancer team, Inserm, U900, Paris, France.
  • Lush M; Institut Curie Paris, Paris, France.
  • Beesley J; Mines ParisTech Fontainebleau, Paris, France.
  • O'Mara TA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dennis J; PSL University Paris, Paris, France.
  • Tyrer JP; Paris Sud University, Orsay, France.
  • Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • McGuffog L; Department of Genetics and Computational Biology QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Leslie G; Department of Genetics and Computational Biology QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Adank MA; Centre for Cancer Genetic Epidemiology, Department of Oncology University of Cambridge, Cambridge, UK.
  • Agata S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ahearn T; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Aittomäki K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Anton-Culver H; Family Cancer Clinic, The Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Arndt V; Immunology and Molecular Oncology, Unit Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Arnold N; Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Aronson KJ; Department of Clinical Genetics, Helsinki University Hospital University of Helsinki, Helsinki, Finland.
  • Arun BK; Fred A. Litwin Center for Cancer Genetics Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Augustinsson A; Department of Molecular Genetics University of Toronto, Toronto, ON, Canada.
  • Azzollini J; Department of Epidemiology, Genetic Epidemiology Research Institute University of California Irvine, Irvine, CA, USA.
  • Barrowdale D; Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Baynes C; Department of Gynaecology and Obstetrics University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Becher H; Institute of Clinical Molecular Biology University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Bermisheva M; Department of Public Health Sciences, and Cancer Research Institute Queen's University, Kingston, ON, Canada.
  • Bernstein L; Department of Breast Medical Oncology University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bialkowska K; Department of Cancer Epidemiology, Clinical Sciences Lund University, Lund, 22242, Sweden.
  • Blomqvist C; Unit of Medical Genetics, Department of Medical Oncology and Hematology Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bojesen SE; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Bonanni B; Centre for Cancer Genetic Epidemiology, Department of Oncology University of Cambridge, Cambridge, UK.
  • Borg A; Institute for Medical Biometrics and Epidemiology University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brauch H; Institute of Biochemistry and Genetics Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Brenner H; Department of Population Sciences Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Burwinkel B; Department of Genetics and Pathology Pomeranian Medical University Szczecin, Szczecin, Poland.
  • Buys SS; Department of Oncology, Helsinki University Hospital University of Helsinki, Helsinki, Finland.
  • Caldés T; Department of Oncology Örebro University Hospital, Örebro, Sweden.
  • Caligo MA; Copenhagen General Population Study, Herlev and Gentofte Hospital Copenhagen University Hospital, Herlev, Denmark.
  • Campa D; Department of Clinical Biochemistry, Herlev and Gentofte Hospital Copenhagen University Hospital, Herlev, Denmark.
  • Carter BD; Faculty of Health and Medical Sciences University of Copenhagen, Copenhagen, Denmark.
  • Castelao JE; Division of Cancer Prevention and Genetics IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Chang-Claude J; Department of Oncology Lund University and Skåne University Hospital, Lund, Sweden.
  • Chanock SJ; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Chung WK; iFIT-Cluster of Excellence University of Tübingen, Tübingen, Germany.
  • Claes KBM; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Clarke CL; Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Collée JM; Molecular Epidemiology Group, C080 German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Conroy DM; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg University of Heidelberg, Heidelberg, Germany.
  • Czene K; Department of Medicine Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Daly MB; Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Nat Commun ; 12(1): 2986, 2021 May 14.
Article em En | MEDLINE | ID: mdl-33990587
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido